Calorie Restriction and Changes in Body Composition, Disease, Function, and Quality of Life in Older Adults
This study is currently recruiting participants.
Verified March 2013 by University of Alabama at Birmingham
Sponsor:
University of Alabama at Birmingham
Information provided by (Responsible Party):
Jamy Ard, MD, University of Alabama at Birmingham
ClinicalTrials.gov Identifier:
NCT00955903
First received: August 6, 2009
Last updated: March 15, 2013
Last verified: March 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The investigators want to determine if the benefits of weight loss outweigh the potential risk in a group of older adults. The investigators will test the hypothesis that changes in diet composition alone or in conjunction with weight loss will have a significant effect on fat stores, and as a result, improve cardiometabolic risk factors and functional status in adults 65 and older.
| Condition | Intervention | Phase |
|---|---|---|
|
Obesity Diabetes Hypertension Hyperlipidemia |
Behavioral: Exercise and Diet in Older Adults |
Phase 3 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Factorial Assignment Masking: Open Label Primary Purpose: Prevention |
Resource links provided by NLM:
MedlinePlus related topics:
Diabetes Medicines
Exercise and Physical Fitness
High Blood Pressure
Obesity
Weight Control
U.S. FDA Resources
Further study details as provided by University of Alabama at Birmingham:
Primary Outcome Measures:
- Change in abdominal fat mass [ Time Frame: 1 year ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- cardiometabolic risk factors [ Time Frame: 1 year ] [ Designated as safety issue: No ]
- weight change/maintenance [ Time Frame: 1 year ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 180 |
| Study Start Date: | June 2010 |
| Estimated Primary Completion Date: | January 2014 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Weight Loss
Participants will participate in supervised exercise sessions plus follow a reduced calorie diet
|
Behavioral: Exercise and Diet in Older Adults
Participants will participate in a behavioral intervention involving exercise only for the control group, weight maintenance diet and exercise for one intervention, and weight loss diet with exercise for the final group.
|
|
Active Comparator: Control
Participants are involved in exercise only intervention
|
Behavioral: Exercise and Diet in Older Adults
Participants will participate in a behavioral intervention involving exercise only for the control group, weight maintenance diet and exercise for one intervention, and weight loss diet with exercise for the final group.
|
|
Active Comparator: Weight Maintenance
participants are involved in exercise and a weight maintenance diet
|
Behavioral: Exercise and Diet in Older Adults
Participants will participate in a behavioral intervention involving exercise only for the control group, weight maintenance diet and exercise for one intervention, and weight loss diet with exercise for the final group.
|
Eligibility| Ages Eligible for Study: | 65 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- at least 65 years of age
- BMI 27 - 42 kg/m2 - at increased health risk (taking at least 1 medication for hypertension, hyperlipidemia, or type 2 diabetes)
Exclusion Criteria:
- difficulties chewing or swallowing food
- digestive diseases that may affect the ability to follow a high fiber diet
- cognitive impairment
- depression
- recent weight change (+/- 10 lbs in the last 12 months)
- poorly controlled blood pressure
- history of non-skin cancer in last 5 years
- cardiovascular disease event in past 6 months or severe pulmonary disease or renal failure
- major liver dysfunction
- current smoker or quit less than months prior
- history of prior surgical procedures for weight control or liposuction
- use of estrogen or testosterone replacement therapy
- current use of insulin or sulfonylurea agents
- current use of corticosteroids > 5 days/month on average
- current use of medications for treatment of psychosis or manic-depressive illness
- use of weight-loss medications in previous 3 months
- dependence on others for food procurement or preparation
- ischemic changes on exercise treadmill test
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00955903
Contacts
| Contact: Marilyn Hass | 205-934-7918 | mhaas@uabmc.edu |
| Contact: Brooks C Wingo, PhD | 205-996-5029 | bcwingo@uab.edu |
Locations
| United States, Alabama | |
| University of Alabama at Birmingham | Recruiting |
| Birmingham, Alabama, United States, 35294 | |
| Principal Investigator: Jamy D Ard, MD | |
| Principal Investigator: Julie L Locher, PhD MSPH | |
Sponsors and Collaborators
University of Alabama at Birmingham
Investigators
| Principal Investigator: | Jamy D Ard, MD | University of Alabama at Birmingham |
| Principal Investigator: | Julie Locher, PhD | University of Alabama at Birmingham |
More Information
No publications provided
| Responsible Party: | Jamy Ard, MD, Associate Professor, University of Alabama at Birmingham |
| ClinicalTrials.gov Identifier: | NCT00955903 History of Changes |
| Other Study ID Numbers: | F090430012 |
| Study First Received: | August 6, 2009 |
| Last Updated: | March 15, 2013 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by University of Alabama at Birmingham:
|
glucose insulin lipids C-reactive protein adiponectin |
leptin TNF alpha IL-6 Quality of Life functional status |
Additional relevant MeSH terms:
|
Hyperlipidemias Hypertension Obesity Dyslipidemias Lipid Metabolism Disorders Metabolic Diseases Vascular Diseases |
Cardiovascular Diseases Overnutrition Nutrition Disorders Overweight Body Weight Signs and Symptoms |
ClinicalTrials.gov processed this record on May 19, 2013